BroadOak

BroadOak

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Axol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease models

Axol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease models

Axol Bioscience

Axol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease models

Axol Bioscience supplies stem cell-derived disease models to researchers, supporting drug discovery with more human-relevant biology.

BroadOak

More venture news

4 Mar 2026
Vivox AI raises £1.3m from investors to tackle financial crime compliance with atomic agents
EquityFintech
Callosum
26 Feb 2026
Callosum unlocks £7.5m in funding led by Plural to challenge single-chip AI systems
EquityAI
5 Mar 2026
Plato secures £260k in funding from SFC Capital for structured AI study support in universities
EquityEducation